Publicação científica trimestral do CREMERJ - volume 3 - número 1 - 2024

18 Importância do Microbioma Intestinal em Gastroenterologia Maria do Carmo Friche Passos Med. Ciên. e Arte , Rio de Janeiro, v.3, n.1, p.7-18, jan-abr 2024 23. Askari H, Shojaei-Zarghani S, Raeis-Abdollahi E, Jahromi HK, Abdullahi PR, Daliri K, et al. The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art. Mini Rev Med Chem. 2023;23(13):1376-1389. 24. Campaniello D, Bevilacqua A, Speranza B, Racioppo A, Sinigaglia M, Corbo MR. A narrative review on the use of probiotics in several diseases. Evidence and perspectives. Front Nutr. 2023;10:1209238.  25. Chibbar R, Dieleman LA. The Gut Microbiota in Celiac Disease and probiotics. Nutrients. 2019;11(10):2375. 26. Bascuñán KA, Araya M, Roncoroni L, Doneda L, Elli L. Dietary Gluten as a Conditioning Factor of the Gut Microbiota in Celiac Disease. Adv Nutr.;11(1):160-174. 27. Abreu MT, Peek RM Jr. Gastrointestinal Malignancy and the Microbiome. Gastroenterology. 2014; 146:1534-46. 28. Park EM, Chelvanambi M, Bhutiani N, Kroemer G, Zitvogel L, Wargo JA. Targeting the gut and tumor microbiota in cancer. Nat Med. 2022;28(4):690-703.  29. Wong-Rolle A, Wei HK, Zhao C, Jin C. Unexpected guests in the tumor microenvironment: microbiome in cancer. Protein Cell. 2021;12(5):426-35. 30. Amieva M, Peek RM Jr. Pathobiology of Helicobacter pylori-induced Gastric Cancer. Gastroenterology. 2016;150:64-78. 31. WongCC, Yu J. Gutmicrobiota in colorectal cancer development and therapy. Nat RevClinOncol.;20(7):429-52.  32. Orlando A, Refolo MG, Messa C, Amati L, Lavermicocca P, Guerra V, et al. Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines. Nutr Cancer. 2012;64(7):1103-11. 33. Cai J, Rimal B, Jiang C, Chiang JYL, Patterson AD. Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther. 2022;237:108238.  \ 34. Liu BN, Liu XT, Liang ZH, Wang JH. Gut microbiota in obesity. World J Gastroenterol. 2021;27(25):3837-50. 35. Fang J, Yu CH, Li XJ, Yao JM, Fang ZY, Yoon SH, et al. Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications. Front Cell Infect Microbiol. 2022;12:997018.